Ansider Title Company Date Price Return Shares Value
Traversa Sergio Chief Executive Officer RELMADA THERAPEUTICS, INC. (RLMD) 2025-05-20 $0.50 0.0% 350,000 $174,713
Shenouda Maged Chief Financial Officer RELMADA THERAPEUTICS, INC. (RLMD) 2025-05-20 $0.49 0.0% 200,000 $97,208
Ence Chuck CA and CO RELMADA THERAPEUTICS, INC. (RLMD) 2025-05-16 $0.45 0.0% 228,961 $103,330
Kelly Paul Edward Chief Operating Officer RELMADA THERAPEUTICS, INC. (RLMD) 2025-05-16 $0.43 0.0% 200,000 $86,060
Shenouda Maged Chief Financial Officer RELMADA THERAPEUTICS, INC. (RLMD) 2024-09-11 $2.80 0.0% 53,432 $149,701
Traversa Sergio Chief Executive Officer RELMADA THERAPEUTICS, INC. (RLMD) 2024-09-11 $2.82 0.0% 140,000 $395,115
Casamento Charles J Non-Executive Director RELMADA THERAPEUTICS, INC. (RLMD) 2024-09-09 $2.56 0.0% 13,000 $33,280
Kelly Paul Edward Non-Executive Director RELMADA THERAPEUTICS, INC. (RLMD) 2024-09-09 $2.59 0.0% 25,000 $64,750
Ence Chuck CA and CO RELMADA THERAPEUTICS, INC. (RLMD) 2024-01-31 $3.87 -37.5% 38,970 $150,920
Shenouda Maged Chief Financial Officer RELMADA THERAPEUTICS, INC. (RLMD) 2024-01-31 $3.85 -37.1% 32,675 $125,717
Traversa Sergio Chief Executive Officer RELMADA THERAPEUTICS, INC. (RLMD) 2024-01-31 $3.87 -37.4% 100,000 $386,738
O'Gorman Cedric Chief Medical Officer RELMADA THERAPEUTICS, INC. (RLMD) 2023-05-23 $3.18 -23.9% 10,000 $31,800
Traversa Sergio Chief Executive Officer RELMADA THERAPEUTICS, INC. (RLMD) 2022-12-08 $2.10 15.5% 55,250 $115,804